Aubron-Olivier C - Search Results

1

Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients.

Valantin MA, Bittar R, de Truchis P, Bollens D, Slama L, Giral P, Bonnefont-Rousselot D, Pétour P, Aubron-Olivier C, Costagliola D, Katlama C; TOTEM trial group. Valantin MA, et al. Among authors: aubron olivier c. J Antimicrob Chemother. 2010 Mar;65(3):556-61. doi: 10.1093/jac/dkp462. Epub 2010 Jan 6. J Antimicrob Chemother. 2010. PMID: 20053692 Clinical Trial.

2

Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.

Marcelin AG, Charpentier C, Wirden M, Landman R, Valantin MA, Simon A, Katlama C, Yeni P, Descamps D, Aubron-Olivier C, Calvez V. Marcelin AG, et al. Among authors: aubron olivier c. J Antimicrob Chemother. 2012 Jun;67(6):1475-8. doi: 10.1093/jac/dks047. Epub 2012 Feb 26. J Antimicrob Chemother. 2012. PMID: 22371439

3

Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS study.

Dominguez S, Ghosn J, Peytavin G, Izzedine H, Wirden M, Ktorza N, Miller M, Aubron-Olivier C, Trylesinski A, Calvez V, Deray G, Katlama C. Dominguez S, et al. Among authors: aubron olivier c. J Med Virol. 2007 Feb;79(2):105-10. doi: 10.1002/jmv.20769. J Med Virol. 2007. PMID: 17177308 Clinical Trial.

4

Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.

Valantin MA, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen H, Bousquet R, Katz P, Costagliola D, Katlama C. Valantin MA, et al. Among authors: aubron olivier c. AIDS. 2003 Nov 21;17(17):2471-7. doi: 10.1097/00002030-200311210-00009. AIDS. 2003. PMID: 14600518

5

Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.

Jouan M, Savès M, Tubiana R, Carcelain G, Cassoux N, Aubron-Olivier C, Fillet AM, Nciri M, Sénéchal B, Chêne G, Tural C, Lasry S, Autran B, Katlama C; RESTIMOP study team. Jouan M, et al. AIDS. 2001 Jan 5;15(1):23-31. doi: 10.1097/00002030-200101050-00006. AIDS. 2001. PMID: 11192865 Clinical Trial.

6

Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonates.

Benaboud S, Ekouévi DK, Urien S, Rey E, Arrivé E, Blanche S, Gray G, Sim KL, Avit D, McIntyre J, Nerrienet E, Dabis F, Tréluyer JM, Hirt D; TEmAA ANRS 12109 Study Group. Benaboud S, et al. Antimicrob Agents Chemother. 2011 Jan;55(1):331-7. doi: 10.1128/AAC.00631-10. Epub 2010 Oct 18. Antimicrob Agents Chemother. 2011. PMID: 20956588 Free PMC article. Clinical Trial.

7

Primary infection with a lamivudine-resistant hepatitis B virus.

Thibault V, Aubron-Olivier C, Agut H, Katlama C. Thibault V, et al. AIDS. 2002 Jan 4;16(1):131-3. doi: 10.1097/00002030-200201040-00020. AIDS. 2002. PMID: 11741175 No abstract available.

8

Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient.

Thabut D, Thibault V, Benhamou Y, Bernard B, Aubron-Olivier C, Poynard T, Di Martino V. Thabut D, et al. Among authors: aubron olivier c. AIDS. 2001 Dec 7;15(18):2463-4. doi: 10.1097/00002030-200112070-00020. AIDS. 2001. PMID: 11774835 No abstract available.

9

Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.

Lortholary O, Roussillon C, Boucherie C, Padoin C, Chaix ML, Breton G, Rami A, Veziris N, Patey O, Caumes E, May T, Molina JM, Robert J, Tod M, Fagard C, Chêne G; ANRS 129 BKVIR Trial Group. Lortholary O, et al. J Antimicrob Chemother. 2016 Mar;71(3):783-93. doi: 10.1093/jac/dkv384. Epub 2015 Dec 17. J Antimicrob Chemother. 2016. PMID: 26679250

10

Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance.

TEmAA ANRS 12109 Study Group; Arrivé E, Chaix ML, Nerrienet E, Blanche S, Rouzioux C, Avit D, Kruy LS, McIntyre J, Say L, Gray G, Ekouévi DK, Dabis F. TEmAA ANRS 12109 Study Group, et al. AIDS. 2010 Oct 23;24(16):2481-8. doi: 10.1097/QAD.0b013e32833e1659. AIDS. 2010. PMID: 20827166 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page